Literature DB >> 7519538

An evaluation of antimicrobial treatment for Whipple's Disease. Tetracycline versus trimethoprim-sulfamethoxazole.

G E Feurle1, T Marth.   

Abstract

Whipple's disease is a multisystemic disorder in which almost all organ systems can be invaded by rod-shaped bacteria. Without extended antimicrobial therapy, its course is lethal. Empirically, treatment consists of tetracyclines given for one to two years. Trimethoprim-sulfamethoxazole, a compound that crosses the blood-brain barrier, has been suggested as an alternative when patients were observed with progressive cerebral involvement. There has never been a formal evaluation of the selection of antibiotics for the treatment of Whipple's disease. In the present nonrandomized, partially retrospective study, we compared the result of two treatment regimens in 30 patients, all examined personally. Twenty-two patients were treated with tetracycline and eight patients with trimethoprim-sulfamethoxazole. In five patients, therapy with tetracycline was changed to another antimicrobial agent because of treatment failure or drug intolerance. The main treatment measure was disappearance of the clinical symptoms such as weight loss, arthritis, malabsorption, fever, edema, central nervous system manifestations, lymphadenopathy, and congestive heart failure. Drug intolerance requiring a change of medication was also considered a treatment failure. We found that trimethoprim-sulfamethoxazole induced complete clinical remission in 12 of 13 treatment cycles, tetracycline in 13 of 22 treatment cycles (P < 0.05; mean difference 33%; 95% confidence interval 8% to 58%). Trimethoprim-sulfamethoxazole was also more efficacious than tetracycline in the treatment of cerebral Whipple's disease. However, trimethoprim-sulfamethoxazole did not prevent cerebral manifestations in all cases. The only deaths due to Whipple's disease occurred in patients with cerebral involvement. It is concluded that treatment with trimethoprim-sulfamethoxazole was significantly superior to that with tetracycline in inducing clinical remission of Whipple's disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519538     DOI: 10.1007/bf02087770

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  HLA B27 and defects in the T-cell system in Whipple's disease.

Authors:  G E Feurle; B Dörken; E Schöpf; V Lenhard
Journal:  Eur J Clin Invest       Date:  1979-10       Impact factor: 4.686

2.  A neuropathologic study of Whipple's disease.

Authors:  J M Powers; S E Rawe
Journal:  Acta Neuropathol       Date:  1979-12       Impact factor: 17.088

Review 3.  The penetration of antibiotics into cerebrospinal fluid and brain tissue.

Authors:  R W Barling; J B Selkon
Journal:  J Antimicrob Chemother       Date:  1978-05       Impact factor: 5.790

4.  Immunological alterations in patients with treated Whipple's disease.

Authors:  F F Martin; J Vilseck; W O Dobbins; C E Buckley; M P Tyor
Journal:  Gastroenterology       Date:  1972-07       Impact factor: 22.682

5.  Intestinal lipodystrophy (Whipple's disease); the immediate and prolonged effect of antibiotic therapy.

Authors:  J M Ruffin; S M Kurtz; W M Roufail
Journal:  JAMA       Date:  1966-02-07       Impact factor: 56.272

6.  Treatment of Whipple's disease with sulphamethoxazole-trimethoprim.

Authors:  L Elsborg; E Gravgaard; N O Jacobsen
Journal:  Acta Med Scand       Date:  1975 Jul-Aug

7.  Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazole.

Authors:  E E Wang; C G Prober
Journal:  J Antimicrob Chemother       Date:  1983-04       Impact factor: 5.790

8.  Reversal of dementia associated with Whipple's disease by trimethoprim-sulfamethoxazole, drugs that penetrate the blood-brain barrier.

Authors:  R J Ryser; R M Locksley; S C Eng; W O Dobbins; F D Schoenknecht; C E Rubin
Journal:  Gastroenterology       Date:  1984-04       Impact factor: 22.682

9.  Meningo-ependymitis in Whipple's disease.

Authors:  L R Lapointe; J Lamarche; A Salloum; R Beaudry
Journal:  Can J Neurol Sci       Date:  1980-05       Impact factor: 2.104

10.  Neurologic disease in patients with treated Whipple's disease.

Authors:  D L Knox; T M Bayless; F E Pittman
Journal:  Medicine (Baltimore)       Date:  1976-11       Impact factor: 1.889

View more
  20 in total

1.  Whipple's disease in a father-daughter pair.

Authors:  D D Dykman; B A Cuccherini; I J Fuss; L W Blum; J E Woodward; W Strober
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

Review 2.  Whipple's disease revisited.

Authors:  S A Misbah; N P Mapstone
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

Review 3.  The diagnosis and treatment of Whipple's disease.

Authors:  T Marth
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

Review 4.  Whipple's disease: a rare disease revisited.

Authors:  Payam Afshar; David C Redfield; Philip A Higginbottom
Journal:  Curr Gastroenterol Rep       Date:  2010-08

Review 5.  Whipple's disease and "Tropheryma whippelii".

Authors:  F Dutly; M Altwegg
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

Review 6.  Whipple's disease.

Authors:  Florence Fenollar; Didier Raoult
Journal:  Curr Gastroenterol Rep       Date:  2003-10

7.  [Refractory intermediate uveitis in the presence of unexplained joint disease. Diagnosis: Tropheryma whipplei (Morbus Whipple)].

Authors:  S Mennel; S Schubert; C Müller
Journal:  Ophthalmologe       Date:  2008-02       Impact factor: 1.059

8.  Whipple's Disease.

Authors:  Klaus Mönkemüller; Lucía C Fry; Steffen Rickes; Peter Malfertheiner
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.725

9.  Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers.

Authors:  Maximilian Schöniger-Hekele; Dagmar Petermann; Beate Weber; Christian Müller
Journal:  Appl Environ Microbiol       Date:  2007-02-02       Impact factor: 4.792

10.  Whipple's Disease in an Afro-Caribbean National.

Authors:  D O Whittle; N P Williams; A M Nicholson; K King-Robinson; R Kirsch; R Riddell; T Mazzulli; M G Lee
Journal:  West Indian Med J       Date:  2014-01-06       Impact factor: 0.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.